Also trades as: PHASQ (OTC) · $vol 0M
PHAS NASDAQ
PhaseBio Pharmaceuticals, Inc.
1W: -42.4%
1M: -62.8%
3M: -94.3%
1Y: -98.3%
3Y: -98.4%
$0.07
Last traded 2022-11-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$61M
+20.2% ▲
5Y CAGR: +71.2%
Total Liabilities
$154M
+103.3% ▲
5Y CAGR: +11.0%
Shareholders Equity
-$93M
-269.2% ▼
Cash & Investments
$42M
+48.6% ▲
5Y CAGR: +62.3%
Total Debt
$8M
-35.3% ▼
Net Debt
-$34M
-112.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $13M | $61M | $74M | $28M | $42M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $13M | $61M | $74M | $28M | $42M |
| Net Receivables | $0 | $233K | $1M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $340K | $1M | $4M | $12M | $7M |
| Total Current Assets | $14M | $63M | $79M | $40M | $49M |
| Property, Plant & Equip. | $302K | $355K | $4M | $10M | $12M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $51K | $43K | $32K | $57K | $57K |
| Total Non-Current Assets | $353K | $398K | $4M | $10M | $12M |
| Total Assets | $14M | $63M | $82M | $50M | $61M |
| — Liabilities — | |||||
| Accounts Payable | $430K | $2M | $3M | $4M | $13M |
| Short-Term Debt | $0 | $0 | $2M | $5M | $5M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $2M |
| Other Current Liabilities | $17M | $3M | $3M | $6M | $8M |
| Total Current Liabilities | $18M | $5M | $8M | $15M | $28M |
| Long-Term Debt | $3M | $8M | $12M | $7M | $2M |
| Other Non-Current Liab. | $91M | $22K | $2M | $54M | $116M |
| Total Non-Current Liabilities | $94M | $8M | $14M | $61M | $126M |
| Total Liabilities | $112M | $12M | $23M | $76M | $154M |
| — Equity — | |||||
| Common Stock | $1K | $25K | $29K | $29K | $48K |
| Retained Earnings | -$99M | -$123M | -$162M | -$261M | -$392M |
| Accumulated OCI | -$2M | -$2M | -$2M | $0 | $0 |
| Total Stockholders Equity | -$97M | $51M | $60M | -$25M | -$93M |
| Total Liabilities & Equity | $14M | $63M | $82M | $50M | $61M |
| — Key Metrics — | |||||
| Total Debt | $15M | $8M | $15M | $12M | $8M |
| Net Debt | $2M | -$54M | -$59M | -$16M | -$34M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |